Aerpio Pharmaceuticals Inc
ARPO
Get informed when a big investor buys or sells
+ FollowMarket Cap$53.67M
Close$
$3.21
46.1% upside
Current Fair Value
46.1% upsideUndervalued by 46.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $53.67 Million |
|---|---|
| Enterprise Value | $18.88 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.33 |
| Beta | 1.65 |
| Outstanding Shares | 69,236,945 |
Return
| Return on Equity | -99.68% |
|---|---|
| Return on Assets | -91.02% |
| Return on Invested Capital | -105.62% |
Valuation & Multiples
| P/E Ratio | -1.32 |
|---|---|
| PEG | 1.01 |
| Price to Sales | - |
| Price to Book Ratio | 2.2 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.15 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data